Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
CJC-1295 No DAC, lacking the DAC component that extends half-life, has relatively rapid onset and shorter duration compared to the extended-release CJC-1295 with DAC formulation
SOURCE : Umbrella Labs
R.BrasilF
It is contraindicated in patients with medical records of hyperthyroidism, glaucoma, or cardiovascular disease
1 Off-label use simply means that the medication is used for purposes other than its FDA-approved use
Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR, et al
US$ 20.62
US$ 28.48
US$ 23.69
